ERBB2 and breast carcinoma: And they have shown good efficacy in patients with metastatic HER2-positive breast cancer (Table 1), providing a therapeutic direction for patients with BM, and some of these further retrospective studies, as well as new studies, have shown efficacy of these drugs in BM.